| Synonyms: | |
| Status: | Approved (2017) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | N01BC01 |
| UNII: | I5Y540LHVR |
| InChI Key | ZPUCINDJVBIVPJ-LJISPDSOSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C17H21NO4 |
| Molecular Weight | 303.36 |
| AlogP | 1.87 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 55.84 |
| Molecular species | BASE |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 22.0 |
| Primary Target | |
|---|---|
| DAT |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | 4-7244 | - | - | - | |
|
Ion channel
Voltage-gated ion channel
Voltage-gated sodium channel
|
- | 49000 | - | - | 20-63 | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Acetylcholine receptor
|
- | - | - | 61397-61400 | - | |
|
Membrane receptor
|
- | - | - | 61397-61400 | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC06 neurotransmitter transporter family
|
- | 66-15800 | - | 32-32000 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Cocaine-Related Disorders | 2 | D019970 | ClinicalTrials |
| Opioid-Related Disorders | 2 | D009293 | ClinicalTrials |
| Substance Withdrawal Syndrome | 1 | D013375 | ClinicalTrials |
| Hypersensitivity | 1 | D006967 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 50-36-2 |
| ChEBI | 27958 |
| ChEMBL | CHEMBL370805 |
| DrugBank | DB00907 |
| DrugCentral | 723 |
| EPA CompTox | DTXSID2038443 |
| FDA SRS | I5Y540LHVR |
| Human Metabolome Database | HMDB0015043 |
| Guide to Pharmacology | 2286 |
| PDB | COC |
| PubChem | 446220 |
| SureChEMBL | SCHEMBL21930 |
| ZINC | ZINC000003875336 |